Breaking
Sunday, June 14, 2026

Regulatory Updates

🇺🇸 FDA Page 13

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.

Showing 145–156 of 382 articles

High impact AnalysisJun 2, 2026

Personalized mRNA Cancer Vaccines: A New Era for Melanoma Treatment

melanoma · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Cumberland Pharmaceuticals (NASDAQ: CPIX) to divest marketed brands to Apotex for $100M

FDA · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Navigating the Regulatory Landscape: A Strategic Policy Agenda for Private Equity in Healthcare

8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA grants orphan status to oxaliplatin for hard-to-treat pancreatic cancer

FDA · pancreatic cancer · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Gilead Secures First Hepatitis D Drug Approval, Sparking Bay Area Competition

FDA · hepatitis · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Approves MannKind's Afrezza for Pediatric Diabetes Patients

FDA · diabetes · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product

U.S. Food and Drug Administration · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

AbbVie's Decnupaz Secures FDA Approval for Rare Blood Cancer

FDA · blastic plasmacytoid dendritic cell neoplasm · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Eli Lilly's Retatrutide Success Amidst Regulatory Shifts: A Strategic Analysis

FDA · 9 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

FDA Expands ENDS Market Access: Implications for Pharma BD and Investors

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Amgen and Zai Lab Leadership Shifts: Strategic Implications for Pharma BD and Investors

FDA · neurology · 8 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

FDA Approves Atezolizumab for ctDNA MRD-Positive MIBC: A New Era for Adjuvant Therapy

FDA · muscle invasive bladder cancer · 7 min

Dr. Sarah Mitchell